Artificial system

DRAP behind artificial shortage of analgesic drugs, alleges PYPA – Pakistan

ISLAMABAD: The Pakistan Young Pharmacists Association (PYPA) has accused the Pakistan Drug Regulatory Authority (DRAP) and GSK Pharma of creating an artificial shortage of fever-relieving tablets, Panadol 500mg, at a time where 60% of the land area of ​​the country is flooded and facing dengue fever, malaria and other communicable diseases aiming to promote the sale of globally banned 665mg tablets.

In a letter written to the Prime Minister of Pakistan and other relevant authorities, Dr Furqan Ibrahim, General Secretary of PYPA, said that at any given time, more than 60% of Pakistan is under flood waters and that the poor are fighting for their lives and that thousands have already died. , the DRAP ordered the pharmaceutical industry to immediately halt the manufacture of life-saving drugs to blackmail the government with the aim of securing a 50% price increase. The association said that due to the negligence of the DRAP, there is a shortage of about 100 life-saving drugs in the country.

If GSK Pharma and City Pharma are unable to produce and supply paracetamol to the population, the government can impose a compulsory license, take over the factories of GSK Pharma and City Pharma; PYPA is ready to assist the government and will not only ensure the availability of paracetamol at less than Rs 1.5 per pill, but also eliminate the drug shortage within 15 days.

Copyright Business Recorder, 2022